Form 4: Strata Skin Sciences Director Acquires 20,000 Stock Options
SEC Form 4 Filing
Christina L Allgeier, a director of Strata Skin Sciences, acquired 20,000 stock options on October 29, 2024.
Summary
- On October 29, 2024, Christina L Allgeier, a director of Strata Skin Sciences, Inc. (SSKN), acquired 20,000 stock options.
- The options have an exercise price of $3.175.
- The options become exercisable on October 29, 2025, and expire on October 29, 2034.
- Following the transaction, Allgeier beneficially owns 20,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing regarding stock option acquisition, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders, aligning the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/29/2024 | Date of transaction: Director acquired 20,000 stock options. |
| 10/29/2025 | Options become exercisable. |
| 10/29/2034 | Options expiration date. |
| 10/30/2024 | Date of signature. |
Keywords
stock options, director, Strata Skin Sciences, SSKN, Form 4, beneficial ownership, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.